| LY2780301 : Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study |
PD0325901: Targeted elimination of senescent Ras-transformed cells by suppression of MEK/ERK pathway